SynAgile's Unattributed Round

SynAgile raised a round of funding on May 04, 2011.

SynAgile is developing DopaFuse, designed to be the first patient-friendly, noninvasive therapy for continuous delivery of L-DOPA and carbidopa. The medication is delivered from a small, comfortable d…

Articles about SynAgile's Unattributed Round: